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by  
Lam Ngoc Thao Nguyen 
 
In this thesis, we investigated T cell homeostasis and DNA damage repair machineries in HIV 
infection. We found that the frequencies of CD4T cells were low, which is associated with cell 
apoptosis in HIV patients compared to healthy subjects.  Importantly, these events were closely 
correlated to the increase in T cell exhaustion, senescence, DNA damage, and telomere attrition. 
Mechanistically, while the DNA damage sensors Mer11, Rad50, and NBS1 (MRN) complexes 
remained intact, the ataxia-telangiectasia mutated (ATM) kinase and its downstream checkpoint 
kinase 2 (CHK2) were significantly inhibited during HIV infection. Additionally, telomeric 
repeat-binding factor 2 (TRF2) that functions to protect telomeres from unwanted DNA damage 
was also suppressed by HIV infection. These findings revealed an important mechanism by 
which telomeres undergo DNA damage that remained unrepaired due to ATM deficiency and 
TRF2 deprotection - a process that could promote T cell apoptosis, senescence, and cellular 
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 Human immunodeficiency virus (HIV) infection is known to originate from the rural 
areas of Central Africa in the late 1800s. It is believed that simian immunodeficiency virus 
(SIV), an immunodeficiency virus in chimpanzees, was transmitted from apes to humans and 
mutated into HIV when hunters had contact with the infected blood while handling the bush 
meat of the infected animals in the southeastern part of Cameroon. From there, HIV infection 
was present in low levels in remote Africa until it was carried down the Congo River to 
Leopoldville (became Kinshasa in 1986), which was a very popular growing area at the time. 
Over the decades, HIV infection slowly spread into other parts of Africa, and eventually became 
an epidemic over the world. HIV infection was first detected in the United States (US) in the mid 
to late 1970s 1. 
 According to a report by the Centers for Disease Control and Prevention (CDC), by the 
end of 2015, it was estimated that approximately 1.1 million people in the US were living with 
HIV infection, in which about 15%, or, only 1 in 7 of that population, were aware that they were 
infected by HIV. There were 38,739 newly diagnosed HIV cases in the US in 2017. The most 
popular mode of transmission is through male to male sexual contact, followed by heterosexual 
contact, and intravenous drug use being the least. Studies showed that Black/African Americans 
were the highest population infected with HIV; this is followed by Caucasians, and Hispanics 
and Asians being the least affected populations. In 2016, there were 15,807 deaths in relation to 
HIV and acquired immunodeficiency syndrome (AIDS) in the US. HIV infection continues to 
cause serious global health burden with an estimated 1.8 million newly diagnosed cases in 2017; 
940,000 deaths from HIV/AIDS-related health issues in 2017 and about 36.9 million people 
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living with HIV infection globally. Among these, only 21.7 million people have access to 
antiretroviral therapy (ART).  
 Currently, there is no effective cure for HIV/AIDS. However, HIV infection can be 
controlled if the infected individuals are treated with highly active antiretroviral therapy 
(HAART), which can effectively suppress the replication of HIV. Therefore, under effective 
ART, the viral load (measured by real-time RT-PCR for the amount of HIV-RNA present in 
blood) of infected subjects is not detectable, and this helps them to live healthy lives with little or 
no risk of transmitting HIV to others sexually. However, if infected individuals fail to take their 
ART, they would suffer serious complications from the HIV infection. 
 There are three stages of HIV infection. The first stage (called acute HIV infection) 
presents with flu-like symptoms and usually lasts for about two to four weeks. During this stage, 
the viral load is extremely high in the patient’s blood. Following the acute phase is the clinical 
latency stage, also called chronic infection. During this phase, the viruses are still in the active 
state; however, viral replication occurs at very low levels. This phase is also associated with a 
decrease in the number of CD4T cells at the rate of ~100 CD4T cells/per year. This phase can 
last for 8-10 years and can progress to AIDS in untreated individuals. The last stage, called 
AIDS, is defined by CD4T cells count below 200 cells per milliliter of blood. At this stage, the 
patients present with chills, fever, weakness, weight loss, and AIDS defining illness. At this 
phase, their immune system is badly damaged and this results in opportunistic infections, 
malignancies, and death.  
 HIV is a retrovirus, which belongs to Retroviridae viral family. The retrovirus genome 
possesses a single, positive stranded RNA. As a retrovirus, it has the ability to reverse-transcribe 
its RNA into DNA using the reverse transcriptase enzyme. Following reverse transcription, the 
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viral DNA is incorporated into the host genome by an integrase. Then, the inserted viral DNA is 
continuously transcribed and translated together with the host DNA to produce new viruses 
indefinitely. HIV belongs to the Lentivirus subgroup which is characterized by a long incubation 
period, causing latent and/or chronic infection in humans and other mammalian species 2. 
 HIV mainly targets the CD4T lymphocytes. The human immune system is divided into 
two main immunity mechanisms.  Innate immunity is the first line of defense, which provides 
fast, non-specific responses to external stimulation or pathogenic infections. The other strategy is 
adaptive immunity. It is present only in vertebrates and provides highly specialized immune cells 
to fight the infectious pathogens. The cells involved in adaptive immunity are called 
lymphocytes. There are three main groups of lymphocytes: T cells, which mediate cellular 
immunity, B cells, which mediate humoral immunity, and the natural killer cells. There are two 
types of T lymphocytes, CD4 (T helper cells) and CD8+ (cytotoxic T cells) 3-4.  
 The interactions of HIV viral glycoproteins 120 (gp120) and the CD4receptors along with 
chemokine co-receptors (CCR5, CXCR4) present on the surface of T helper cells facilitate the 
attachment and entry of HIV, and allow for the fusion of viral particles into the host cells. Once 
inside the cytoplasm of host cell, viral RNA is reverse transcribed into DNA, which is then 
incorporated into the host genome. When activated, the host cells start to initiate transcription 
and translation processes to produce proteins.  These proteins, together with viral polypeptides 
(which later fold into proteins), assemble into new viral particles, release and lead to reinfection 
of adjacent cells 5-6. The indefinite production and infection of new viral particles triggers the 
continuous maturation and responses of CD4T cells, which in turn trigger the responses from 
CD4naïve and central memory T cells to produce more effector cells in order to keep pace with 
the viral production rate. Long-term viral infection results in increased CD4T cells turnover, 
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which leads to alteration of immune homeostasis and cell loss. This is the main cause of short-
lived and/or dysfunctional CD4T cells 7.  
 It has been reported that ongoing inflammation associated with progressive HIV infection 
is the reason for CD4T cells exhaustion, senescence, and telomere shortening. Chronic HIV 
infection can significantly induce DNA damage response (DDR) and cell apoptosis. While 
Vicente Planelles and his group reported that infectious viruses, including HIV, encode gene 
products that can activate the G2 cell cycle arrest, trigger the DDR, and lead to cell apoptosis 8; 
reports published by Guido Kroemer’s group showed that the viral envelope glycoprotein 
complex activates the DDR pathway via the phosphorylation of ataxia-telangiectasia mutated 
(ATM) kinase and its downstream effector proteins, such as CHK2 and P53, which will 
eventually cause cell apoptosis 9. Also, Dorota Piekna-Przybylska’s group suggested that in vitro 
HIV-infected cell lines induce deficiency of the DDR even though the viruses are in the latent 
phase 10. Taken together, these reports suggest that chronic HIV infection induces DNA damage 
in exhausted and senescent CD4T cells. Despite intensive research, the mechanisms by which 
HIV infection causes DNA damage, cellular apoptosis, and senescence remain poorly 
understood. 
 There are several proposed mechanisms by which HIV infection causes DNA damage 
and telomere erosion. One possibility may be the insufficiency in the DNA repair kinase ATM, 
along with its downstream signaling kinase CHK2 in HIV-infected CD4T cells. ATM, ATM and 
Rad3-Related (ATR), and DNA-dependent protein kinase c (DNA-PKc) are the main DNA 
repair enzymes, and they belong to the phosphatidylinositol-3-kinase-like kinase family (PIKKs). 
While the ATR pathway responds to single-stranded DNA breaks (SSBs), ATM and DNA-PKc 
facilitate the repair of double-stranded DNA breaks (DSBs) 11. Following DSBs, the MRN 
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complex, which is formed by the association of MRE11, RAD50 and Nijmegen breakage 
syndrome (NBS1), acts as the sensor of the ATM pathway, quickly moving to the site of DNA 
break and recruiting ATM. ATM is the main transducer of this pathway. Binding of ATM to 
both the DNA sequence and the MRN complex triggers auto-phosphorylation and activation of 
ATM which in turn, phosphorylates mediator proteins, such as tumor suppressor p53-binding 
protein 1 (53BP1), mediator of DNA damage checkpoint protein 1 (MDC1) and checkpoint 
kinase 2 (CHK2). These phosphorylated mediator proteins activate tumor protein 53 (p53) which 
is the main effector protein of the ATM pathway. When active, effector protein p53 transduces 
cell signaling and induces the DNA damage repair machineries in order to protect genomic 
integrity.  
There are four main events involved in DDR. These include cell cycle arrest, DNA 
reparation, cellular apoptosis, and chromatin remodeling. Despite occurring independently, ATM 
plays a central role in all of the processes. In the first event, DSBs trigger auto-phosphorylation 
of ATM and phosphorylation of γH2AX. This sets up the signaling cascade and is closely 
followed by the phosphorylation of CHK2. Phosphorylation of CHK2 activates p53 (acts as 
transcription factor) and moves to the nucleus where it initiates the transcription of p21 protein. 
Activated p21 protein leads to the inhibition of cyclin-dependent kinases, such as CDK2, CDK4, 
and CDK6 whose functions are to block the entry of cells from G1 to S phase. This cell cycle 
arrest is crucial as it prevents the replication of damaged DNA.   
 Furthermore, ATM and CHK2 proteins phosphorylate Wee1 and CDC25 proteins; thus, 
inhibit the activation of CDK1 protein, whose main function is to facilitate the entry into the 
G2/M cell cycle. Once the cell cycles are stalled, damaged DNA is repaired by efforts of non-
homologous ends joining (NHEJ) or homologous recombination (HR) mechanisms. However, if 
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the DNA damage is irreparable, p53 protein is phosphorylated by ATM, activating several pro-
apoptotic factors, such as PUMA, Bax, Bak and Nox. These factors enhance the permeability of 
mitochondrial membrane, leading to the leakage of cytochrome C as well as other luminal 
contents which activate apoptosis 12-15. In general, there are many proteins that participate in the 
ATM DDR; however, the crucial proteins are the MRN complex, ATM, CHK2 and p53 proteins. 
Dysfunction or deficiency of any of these proteins results in the impairment of this important 
pathway, causing an increase in the level of un-repaired DNA damage. Thus, affecting genomic 
integrity and cell survival.  
 ATM deficiency has been implicated in a wide range of cellular and systemic diseases. 
Studies done in both cell lines and mice models revealed that ATM deficiency led to genome 
instability as evidenced by nuclear accumulation of 53BP1 and γH2AX, chromosomal 
abnormalities, and inactivation of Poly (ADP-ribose) polymerase (PARP) protein which 
functions as a base excision repair protein. In addition, it has been linked to persistent DNA 
damage, chromosomal alterations, and increased sensitivity to radiation. These aberrant events 
have been shown to have close association with cancers such pancreatic and prostate cancer in 
mice models 16, as well as B cell lymphoma, leukemia 17, and human rheumatoid arthritis 18.  The 
mechanism by which ATM depletion results in malignancy is poorly understood. However, a 
report attributed this to oncogenic activation of WD repeat and SOCS box-containing protein 1 
(WSB1): an E3-ubiqitin ligase, which in turn negatively regulates the expression of ATM by 
promoting ATM ubiquitination at K1323 and K2025 positions 19. Anthony T Tubbs and Barry P 
Sleckmanin, in their study with mice models, revealed that a mutation in the ATM gene led to a 
defect in T cell maturation; and therefore, defects in cell cycle checkpoint dysfunction, 
hypersensitivity to γ irradiation, and increase in lymphoma incidence 20. Similarly, a study with 
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human models revealed that individuals with the aggressive type of T prolymphocytic leukemia 
(T-PLL) had a deletion in the long arm of chromosomal 11 (where the ATM gene is encoded). 
Furthermore, the deletion of 11q22-23 in the chromosome resulted in the accumulation of mature 
CD5+ B cells, causing B cell chronic lymphocytic leukemia: the most common type of 
hematologic malignancy due to ATM deficiency 21. While ATM deficiency and its role in 
malignancy have been extensively studied in vitro and in animal models, there have been very 
few reports about the role of ATM dysfunction in HIV infections.  
 Dysfunction of the telomeres and its associated binding proteins could be another 
contributing factor to the increase in DNA damage and cellular apoptosis in latent HIV infection. 
Telomeres are repetitive nucleotide sequences, bound by several telomeric interacting proteins 
which function to protect the chromosomal ends from degradation and DNA damage. Telomeric 
DNA consist of double-stranded hexameric tandem repeats (TTAGGG) and single-stranded 3’ 
G-rich overhangs. Telomeres are continuously lengthened by telomerase, a unique 
ribonucleoprotein complex consisting of a catalytic subunit, telomerase reverse transcriptase 
enzyme (TERT), and a telomere RNA complex component (TERC) that acts as a template for 
telomere extension. The telomere is in turn protected by a complex of six proteins, known as 
shelterin or telosome. Those proteins are telomeric repeat-binding protein 1 (TRF1), telomeric 
repeat-binding protein 2 (TRF2), TRF1 and TRF2 interacting nuclear protein 2 (TIN2), 
protection of telomere 1 (POT1), TIN2 and POT1 interacting protein 1 (TPP1), and repressor 
activator protein 1 (RAP1). The assembly of the shelterin complex on telomeric DNA begins 
with the binding of TRF1 and TRF2 proteins to the double-stranded repeat DNA sequence, 
which then recruits the presence of TIN2 and RAP1 proteins. TIN2 protein in turn recruits the 
TPP1 and POT1 complex to the nucleus 22-24. While the telomeres play a crucial role in 
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preventing cellular senescence and maintaining genome integrity, telomeric attrition or 
dysfunction triggers the DDR machinery causing cell apoptosis.  
 In a study using mice models, components of the shelterin complex were knocked out in 
vitro by CRISPR/Cas9. The results showed that TRF2 and RAP1 knockout (KO) had little 
impact on the binding of TRF1 to the double-stranded DNA. In contrast, knock out of TIN2 
significantly affected the functions of both TPP1 and POT1 proteins. Similarly, the KO of POT1 
or TPP1 had great impacts on TIN2 function. Taken together, it was suggested that these three 
proteins formed a tight complex that was critical for telomere assembly. Furthermore, the study 
also showed that the KO of proteins induced a great amount of telomere dysfunction-induced 
foci (TIF), which recruit and increase the activity of the DDR proteins. For example, KO of 
TRF2 activated the ATM pathway while POT1 or TPP1 KO recruited the ATR pathway 25. In 
another study, it was indicated that telomeric DNA damage was irreparable and caused persistent 
TIF 26.  
 In another study, irradiated cells were examined by confocal microscopy for DDR foci. 
Microscopic analysis revealed that the telomeres were more prone to oxidative DNA damage and 
that these damages were poorly repaired in comparison to those occurring at other parts of the 
chromosome. This was attributed to the greater length of repeated G sequences of telomeres 27. 
Telomere dysfunction has been linked to blood disorders in humans. For example, dysleratoris 
congenita (DC), an inherited disorder characterized by an abnormal skin pigmentation and nail 
dystrophy is thought to occur as a result of telomere dysfunction 28. Similarly, Werner Syndrome 
(WS), a very rare premature aging disease has been thought to be due to telomere attrition. These 
individuals have shortened telomeres, altered telomerase activity, and mutations in helicase, 
which is required for extension of G-rich telomeres 29.  
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 The role of ATM kinase and the telomere proteins in protecting genome integrity was 
explored in individuals infected with Hepatitis C Virus (HCV). Zhao et al reported that chronic 
HCV infection inhibited ATM expression and activation, resulting in naïve CD4T cell DNA 
damage and apoptosis 30. Similarly, TRF2 inhibition accelerated telomere erosion and DNA 
damage in individuals with chronic HCV infection 31. The above studies have emphasized the 
importance of the telomere and shelterin complex, as well as ATM and DDR proteins in 
maintaining genomic integrity and stability.  Thus, impaired function of any of these factors 
would have an enormous negative impact on the cell signaling pathway. 
 The hypothesis for this research is that latent HIV infection alters the function of ATM 














MATERIALS AND METHODS 
Ethics Statement 
 
 The study protocol was approved by the institutional review board (IRB) of East 
Tennessee State University (ETSU) and James H. Quillen VA Medical Center (ETSU/VA IRB, 
Johnson City, Tennessee State). All individuals that participated in the projects were adults and 
signed informed consent forms.  
Subjects 
 
 Two populations participated in this study, including 150 latently HIV infected patients 
and 166 age-matched healthy subjects (HS). HIV-infected individuals were on ART treatment, 
therefore they were virologically suppressed for HIV replication, as evidenced with undetectable 
HIV-RNA level in their blood samples. HS were supplied by Physicians Plasma Alliance (PPA, 
Gray, TN), and they were detected to be negative for HIV, hepatitis B virus (HBV), and hepatitis 
C virus (HCV) infections. 
Cells Isolation and Culture 
 
Peripheral Blood Mononuclear Cells (PBMCs) Isolation 
 
 PBMCs are peripheral blood mononuclear cells. Human PBMCs consist of the following 
cell populations: T lymphocytes, B lymphocytes, natural killer cells (NKs), monocytes and 
dendritic cells. The frequencies of these populations are different among individuals; however, 
typically the lymphocytes (including T lymphocytes, B lymphocytes, and NKs) account for 
around 70 to 90 percent, monocytes occupy 10 to 15 percent, and the dendritic cell population is 
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only 1 to 2 percent. In the lymphocyte population, T lymphocytes accounted for 70 percent with 
a ratio of 2:1 for CD4T cells and CD8+ T cells, respectively. B lymphocytes accounted for 5 to 
10 percent and NKs occupies 5 to 15 percent 32. Since CD4T cells are the main interest cells in 
this study, they are isolated from the mixture of cell populations in the PBMCs. The main 
reagent used in PBMCs isolation is Ficoll–Paque solution (GE Healthcare, Piscataway, NJ) and 
is applied in the technique called density gradient centrifugation separation of mononuclear cells.  
 In brief, the anticoagulant-treated whole blood is diluted with RPMI 1640 medium with 
the ratio of 1:1, and then carefully placed on top of the Ficoll-Paque solution without intermixing 
in the centrifugation tube. Then the tube is taken for centrifugation, which will give rise to the 
formation of layers containing different cell types due to differential migration of cells during the 
centrifugation. The bottom layer is the erythrocytes, which was aggregated by the Ficoll-Paque 
solution, therefore these cells penetrated through the solution to reach the bottom of the tube. 
The immediate layer above the erythrocytes contains the granulocytes. The next layer is the 
Ficoll-Paque solution, while the top layer is the plasma. The interface layer between the Ficoll-
Paque solution and the plasma contains the mononuclear cells.  
 The anticoagulant-treated whole blood was placed into 50 ml centrifugation tube and 
centrifuged at 1500 rpm with acceleration and de-acceleration speeds at 9 for 5 minutes at room 
temperature. The result was the formation of the two layers, in which the top layer contained the 
plasma and the bottom layers contained the mixture of cell populations. The top layer containing 
plasma was removed by pipette, and the remaining solution was mixed thoroughly with the 
RPMI 1640 media with a ratio of 1:1. The mixture was then placed carefully on top of the Ficoll-
Paque solution in another 50 ml centrifugation tube without intermixing. Then the tube was 
centrifuged at 2000 rpm with acceleration and de-acceleration speeds at 1 for 20 minutes at room 
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temperature. After the centrifugation, the solution in the tube was separated into layers from the 
bottom to the top with following orders: erythrocytes, granulocytes, Ficoll-Paque solution, 
mononuclear cells and remaining plasma and platelets. The mononuclear cells were collected 
and transferred into another sterile 50 ml centrifugation tube, then mixed with RPMI 1640 
media. After that, the tube was centrifuged at 1800 rpm with acceleration and de-acceleration 
speeds at 9 for 8 minutes to produce the two layers solution.  The bottom layer contained the 
mononuclear cells and the upper layer contained RPMI 1640 media and remaining platelets. The 
upper layer was then removed and the remaining mononuclear cells could be freshly used for cell 
isolation or could be frozen for later use. If the cells were frozen, they were mixed with RPMI 
1640 media containing DMSO. The mixture was then transferred into cryotubes so that each of 
the tube contained 1 ml of media and 1 x 107 cells. These tubes were stored in liquid nitrogen for 
later use.  
CD4 T Lymphocytes Isolation  
 
 CD4T cells were isolated from PBMCs using the CD4T cell negative selection kit 
purchased from Miltenyi Biotec Inn., Auburn, CA.  
 PBMCs are incubated with cocktails of biotin-conjugated monoclonal anti-human 
antibodies against CD8, CD14 CD15, CD16, CD19, CD36, CD56, CD123, TCRγ/δ and CD235a 
cells, except for CD4 cells, which are the non-target cells. Then the mixture of PBMCs and 
antibodies are incubated with Microbeads which are both conjugated to the monoclonal anti-
biotin antibodies and magnetically tagged. The mixture is transferred and allowed to flow 
through the magnetic column in which the magnetically labeled cells are captured inside the 
column, while the unlabeled cells flow through.  
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 PBMCs were washed with RPMI 1640 media by mixing together in a 5 ml centrifugation 
tube, then centrifuged at 1200 rpm for 5 minutes at room temperature. The supernatant was then 
removed. The cell pellet was re-suspended in 40μl isolation buffer and 10μl of antibody cocktail 
per 107 total cells. Then the mixture was incubated at 4 – 8ºC for 5 minutes. After incubation, 
30μl of isolation buffer and 20μl of microbeads were added into the tube and incubated at 4 – 
8ºC for another 10 minutes. The magnetic column was prepared by being washed with 3 ml of 
isolation buffer. The incubated mixture was transferred into the column and the flow through 
solution was collected and placed into a new 5 ml centrifugation tube, and centrifuged at 1200 
rpm for 5 minutes. The supernatant was removed, the cell pellet was re-suspended with RPMI 
1640 media, called complete media, which had 10% fetal bovine serum (FBS) (Atlanta 
Biologicals, Flowery Branch, GA), 100 IU/ml penicillin and 2mM L-glutamine (Thermo 




 The isolated CD4 T cells were seeded into cell culture plates and incubated in an 
incubator at 37ºC and 5% CO2 atmosphere. After 4 days, cultured CD4 cells were harvested and 
used for the necessary assays. 
Flow Cytometry 
 
 Flow cytometry (FCM) is a useful and rapid tool that is used extensively in scientific 
research for cellular characteristic classification in which the information obtained provides both 
quantitative and qualitative data. FCM classifies cells into distinct populations by measuring 
their individual optical and fluorescence characteristics. Cell components, such as DNA or RNA 
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can be fluorescently tagged and analyzed by FCM. In addition, antibodies conjugated with 
fluorescent dyes can be used to tag specific proteins, including plasma membrane, nuclear 
membrane, and cytosolic proteins which present in different cell types. After being fluorescently 
labelled, the cells are allowed to run through the flow cytometer, by which they pass its light 
source and become excited to a higher energy and give rise to the high energy emission. These 
emissions, or light signals, are immediately detected by photomultiplier tubes and digitized for 
computer analysis. All modern flow cytometers provide multiple fluorescent channels which 
allows for the analysis of several cell properties simultaneously. In this project, FCM was used to 
study different characteristics of distinct cellular populations since each cell type examined 
express different specific proteins, also referred as markers. In addition, cells belonging to one 
cell type also express disparate markers at certain states 33.  
Phenotypic Analysis 
 
 In order to be separated from the mixture of cellular populations in PBMCs, interested 
cell types were bound with specific fluorescent conjugated antibodies and were classified by 
FCM. In this project, CD4 cells were the main target to be studied, therefore, total CD4 and its 
subpopulations were sorted and their characteristics were analyzed by FCM. The extracellular 
marker of total CD4 was CD4+, naïve CD4 was CD4+CD45RA+, and memory CD4 was 
CD4+CD45RA-. The memory CD4 was then further divided into several subsets, including 
central memory (CD4+CD45RA-CCR7+CD28+), effector memory (CD4+CD45RA-CCR7-
CD28+/-) and terminally differentiated memory (CD4+CD45RA-CCR7-CD28+). In this assay, 
each of the antibodies were conjugated with one specific fluorescence, including CD4-FITC, 
CD45RA-PerCP710, CD57-APC (Biolegend, San Diego, CA), CD28-PE (Invitrogen, Carlsbad, 
CA), PD1-FITC (eBioscience, San Diego, CA).  
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Cell Apoptosis Qualification 
 
 Apoptosis, also called programmed cell death, is a normal cellular process where cells are 
induced to die in order to maintain an appropriate cell population during development and aging. 
It also serves as an immune defense when cells are under attack by pathogens, noxious agents, or 
diseases. At certain conditions, cells are marked with apoptosis markers and induced to go under 
apoptotic pathways which eventually results in self-destruction without affecting other adjacent 
cells. Apoptosis and necrosis, a process in which the cells are forced to die under physical or 
chemical pressures, are easy to be mistaken for each other, since both processes induce cell 
deaths. Both of the processes can occur independently, sequentially, or even simultaneously. The 
key difference between them is the way the cells die. When induced by apoptosis, cells die by 
cell shrinkage; therefore, it does not release its cytoplasmic content into the surrounding 
environment and later will be phagocytosed by macrophages or the adjacent cells without 
causing inflammation reactions. Opposite to this mechanism, cells induced by necrosis die by 
bursting and releasing its cytoplasmic content, which can lead to a domino effect of 
inflammation to the whole tissue or organ. The specific morphologies of apoptotic cells are cell 
shrinkage, membrane blebbing, chromosome condensation, nuclear fragmentation, and DNA 
laddering. Apoptosis is considered as an irreversible process by which caspase activation leads to 
cell suicide 34.  
 There are three pathways involved in cell apoptosis, including the extrinsic or death 
receptor pathway, intrinsic or mitochondrial pathway, and perforin/granzyme pathway. These 
three pathways are stimulated by different stimuli and have several distinguishable proteins 
involved. However, they eventually lead to the activation of a common protein kinase called 
caspase-3, which initiates the executive apoptotic pathway that leads to cell death. The stimuli of 
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the extrinsic pathway are death ligands, such as Fas. When bound to its receptor, Fas can activate 
the adaptor protein called FADD, meanwhile, the binding of TNF ligand to its receptor activates 
that TRADD protein. This protein then recruits the binding of FADD and RIP proteins, then the 
complex comes to have an association with procaspase 8 forming death-inducing signaling 
complex (DISC) which in turn phosphorylates the caspase-3 protein.  The perforin/granzyme 
pathway is stimulated by viral infections or tumors and induced under cytotoxic T cell signaling. 
When stimulated, T cells exert its cytotoxic effects on targeted cells via a pathway involving the 
secretion of transmembrane pore-forming molecules called perforin together with cytoplasmic 
granules such as granzyme A or granzyme B. These proteins can act as endonucleases that cleave 
proteins into fragments which can later activate the caspase-3 protein. There are a wide range of 
stimuli that can the activate apoptotic intrinsic pathway, including radiation, hypoxia, viral 
infection, or free radicals. These stimulations cause the opening of mitochondria permeability 
transition pore, resulting in the loss of membrane potential which leads to the leaking of the 
lumen content, including cytochrome c. Cytochrome c is well known for its function in cellular 
respiration inside the lumen of mitochondria; however, when released into the cytoplasm, it 
forms a complex with Apaf-1 and procaspase 9 to form apoptosome, which will later trigger the 
cascade activations of caspase 9 and caspase-3. As mentioned above, all three apoptosis 
pathways lead to the activation of caspase-3, which can phosphorylate CAD endonuclease that 
cleaves proteins such as cytokeratin or PARP. These proteins can cause cellular morphological 
and biochemical changes, eventually leading to cell death 35-36.  
 Currently in scientific research, there are three assays heavily used for the detection of 
apoptotic markers by FCM, including Annexin/7-AAD (BD PharmingenTM PE Annexin V 
Apoptosis Detection Kit I, BD Biosciences, San Jose, CA), and measurement of reactive oxygen 
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species (ROS) (DCFDA-based Cellular ROS Detection Kit, Abcam, Cambridge, MA). One of 
the biochemical features of early apoptosis is the externalization of phosphatidylserine, a 
component of plasma membrane normally inward-facing, to be expressed on the outer layers of 
plasma membrane. This phospholipid therefore acts as a ligand for the phagocytosis signaling of 
adjacent cells to digest the phosphatidylserine expressing cells. Because of its feature, 
phosphatidylserine is immensely used as a marker for apoptosis. Annexin V, a recombinant 
protein that strongly and specifically binds to phosphatidylserine, together with 7-ADD which is 
a fluorescent DNA binding dye indicating the membrane impermeability, can be used to identify 
the apoptotic cells at different states. Cells that stained positive for Annexin V and negative for 
7-AAD are considered to be in early apoptosis. Cells that stained both positive for Annexin V 
and 7-AAD are either at the end stage of apoptosis or already in death. Cells that stained negative 
for both the reagents are alive and not undergoing measurable apoptosis 37. Another method to 
track the apoptotic cells is to measure the activated caspase-3 by using fluorescently conjugated 
antibody against it. This can be achieved by performing intracellular FCM staining 38. The last 
assay used in apoptosis identification is ROS detection. ROS are short-lived and highly reactive 
molecules that play essential roles in cell development such as differentiation, proliferation, cell 
signaling, and immune defense. However, when there is an imbalance in ROS generation and 
antioxidant to neutralize it, ROS can cause serious cellular damages, including damage to 
protein, DNA, lipid, and organelles. Since ROS are a type of free radical, its excessive level can 
trigger the activation of intrinsic apoptosis pathway 39.  
Analysis of Interest Proteins 
 
 The interest protein expressions were measured both in qualification and quantification 
by intracellular staining by FCM, including phosphorylated ATM (pATM) at serine 1981 with 
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PE fluorescence (BioLegend), and phosphorylated CHK2 (pCHK2) at threonine 68 with PE 
fluorescence and γ-H2AX-PE (eBioscience). 
FCM Detailed Protocols 
 
 Extracellular staining. Cultured cells were harvested and washed with cell staining 
buffer by centrifugation at 1200 rpm for 5 minutes, followed by removal of the supernatant. The 
cell pellet was resuspended with 50μl of staining buffer in a 2ml centrifugation tube. The mixture 
was then incubated with 1μl of fluorescence-conjugated antibody for 20 minutes at room 
temperature, light avoided. After the incubation, the tube was centrifuged at 1200 rpm for 5 
minutes, the supernatant was discarded, and the cell pellet was resuspended with 50μl staining 
buffer and ready to be analyzed by FCM.  
  Intracellular staining. Cultured cells were harvested and washed with cell staining 
buffer by centrifugation at 1200 rpm for 5 minutes, followed by removal of the supernatant. The 
cells were then fixed by being resuspended with 100μl diluted formalin solution and incubated in 
the dark at room temperature for 60 minutes. The mixture was then centrifuged at 1200 rpm for 5 
minutes and the supernatant was removed. The cell pellet was resuspended with 2ml of 
permeabilization buffer and centrifuged again at 1200 rpm for 5 minutes.  The supernatant was 
discarded. The cell pellet was then mixed with 100μl permeabilization buffer and 2μl of 
fluorescence-conjugated antibody, then the mixture was incubated in the dark at room 
temperature for 60 minutes. The cell pellet was obtained by centrifugation after the incubation, 
then resuspended with 100μl of staining buffer and ready for FCM analysis.  
 Annexin V/7-AAD staining assay. Cultured cells were harvested and washed with cell 
staining buffer by centrifugation at 1200 rpm for 5 minutes, followed by removal of the. The cell 
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pellet was then resuspended with Camptothesin (already diluted with DMSO) and incubated at 
37ºC in 6 hours. After the incubation, the cells were washed twice with cold PBS and then 
resuspended in 1X binding buffer at a concentration 1x106 cells/ml. 100μl of the mixture was 
then transferred into new tube and 5μl of Annexin V and 5μl of 7-AAD were added. The tube 
was then incubated in the dark at room temperature for 15 minutes. After the incubation, 400μl 
of 1X binding buffer was added and then the cells were ready for FCM analysis.  
 ROS detection assay. The principle of this assay is to measure the concentration of 2’, 
7’- dichlorofluorescein (DCF). The beginning reagent is 2’, 7’- dichlorofluorescin diacetate 
(DCFDA).  After diffusion into the cell, DCFDA is deacetylated by cellular esterase to a non-
fluorescent compound, which is later oxidized by ROS into DCF. DCF is a highly fluorescent 
compound which can be measured by FCM. Cultured cells were harvested and washed with cell 
staining buffer by centrifugation at 1200 rpm for 5 minutes, followed by removal of the. The cell 
pellet was then resuspended with culture media and incubated with 20μM DCFDA for 30 
minutes in the dark at 37ºC. After the incubation, the cells were analyzed by FCM. In this assay, 
tert-butyl hydrogen peroxide (TBHP) was used as positive control. TBHT was prepared by 
diluting 55mM TBHT stock solution in 1X supplemented buffer to achieve 50-250μM 
concentration. The positive control was incubated for 4 hours in the dark at 37ºC before FCM 
analysis.   
Flow-FISH 
 
 Flow-FISH (fluorescent in-situ hybridization) is a cytogenetic technique used for 
quantifying the copy number of specific repetitive element in genomic DNA by the combination 
of the two techniques in which the staining protocol is based in FISH and the copy number is 
analyzed by FCM. This technique is mostly used to determine telomere length in scientific 
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research. The principle of this technique is using a labelled probe able to hybridize to telomere 
repeats in the cell suspension. The telomere length is estimated based on the average fluorescent 
signals quantified by FCM. The fluorescence-conjugated probe used in this assay is a peptide 
nucleic acid (PNA) in which the sugar backbone has been replaced by a neutral peptide-
polyamide backbone. This backbone is highly resistant to the degradations caused by 
endonucleases such as DNase, RNase, protease, or peptidase, which makes it more stable in the 
cell lysate. Another crucial characteristic of this probe is its high affinity and high specificity 
binding to its target DNA sequence, which makes it an ideal tool for the analysis 40.  
 The general protocol used in our project was modified from Flow-FISH method as 
previously described. Isolated PBMCs were stained with CD4-A647 and fixed with cell fixation 
buffer (BioLegend) for 20 minutes at room temperature. After being fixed, the cells were 
incubated with telomere PNA probe TelC (CCCTAACCCTAACCCTAA)-FITC in which the 
concentration is 0.3μg probe/mL (PNA Bio, Newbury Park, CA) at room temperature for 10 min 
in the dark. After that, the cells were incubated at 82°C for another 10 minutes. After the 
incubation, the cells were washed with post-hybridization buffer, followed by flow cytometry 




 Confocal microscopy is an optical imaging technique that can enhance the visualization 
of biological samples by capturing the images at different depths and enable the three-
dimensional reconstruction of the samples. In this project, confocal microscopy is combined with 
immunofluorescence, a technique used in detection of proteins using fluorescently conjugated 
antibodies, in order to determine the telomere function by identifying the localization of telomere 
30 
 
associated proteins and DDR proteins to form DNA damage foci. As mentioned in the 
introduction, telomeres are protected by shelterin which consists of six proteins. When DNA 
damage occurs at the telomere, DDR is triggered and proteins involved in this pathway are 
recruited to the DNA damage sites. Therefore, there must be interactions between the shelterin 
complex and DDR pathway. These associations are called DNA damage foci and are considered 
as DNA damage markers. In this project, the DNA damage foci formed from the associations of 
53BP1, which belongs to the DDR pathway and has binding domains for both p53 proteins and 
modified histone conformations, and TRF1 proteins was used as the telomeric DNA damage 
evaluation. The principle of the procedure is that the permeabilized cells were incubated with 
primary antibodies against 53BP1 and TRF1 proteins, followed by the incubation of secondary 
fluorescent conjugated antibodies and visualized by confocal microscopy.  
 The general protocol was described previously. In brief, cultured cells were harvested and 
washed with cell staining buffer by centrifugation at 1200 rpm for 5 minutes, and the supernatant 
was then removed. The cell pellet was then mixed and fixed by 2% paraformaldehyde solution 
for 20 minutes, followed by cell permeabilization by 0.3% triton X 100 in PBS for 10 minutes. 
After that, the cells were blocked with 5% bovine serum albumin (BSA) in PBS for 1 hour. Then 
the cells were incubated with the primary antibodies against 53BP1 (Cell Signaling) and TRF1 
(Thermo Fisher) at 4ºC overnight. After the incubation, the cells were washed with PBS 
containing 0.1% Tween solution for three times before being incubated with secondary 
fluorescence-conjugated rabbit antibody in the dark for 1 hour. Then, cells were washed with 
PBS and mounted with DAPI fluoromount-G (SouthernBioTech, Birmingham, AL), which is an 
impermeant plasma membrane dye. Finally, cells were visualized under confocal laser-scanning 
inverted microscope (Leica Confocal, Model TCS sp8, Germany). 
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RNA Isolation and Real-time RT-PCR 
 
 In scientific research, the quantity of gene expression is mostly achieved by performing 
RNA isolation followed by the real-time reverse transcription polymerase chain reaction (RT-
PCR) technique. Following the central-dogma flow of genetic information, it is known that the 
term gene expression is preferred to the order of processes which include the transcription of 
RNA based on the DNA sequence and then the translation of protein based on the order of 
nucleic acids present on the transcribed RNA. Therefore, gene expression level can actually be 
measured by the quantification of transcribed RNA levels. Currently, there is no efficient method 
to measure the level of RNA expression; therefore, RNA is usually converted back into 
complementary DNA (cDNA) by RT-PCR, which can be tagged with fluorescence, then 
amplified and quantified by real-time RT-PCR.  
 The total RNA was isolated using the RNeasy Mini Kit (Qiagen). Cultured cells were 
harvested and washed with cell staining buffer by centrifugation at 1200 rpm for 5 minutes, and 
the supernatant was then removed. Then the cells were disrupted by RTL buffer (supplied) so 
that 300μl buffer was used for each of 5x106 cells. Then the cell lysate was homogenized by 
being vortexed for 1 minute. Then 1 volume of cold 70% ethanol was added into the tube 
containing cells, and mixed well. After that, the mixture of approximately 700μl was transferred 
to RNeasy spin column placed on 2ml collection tube (supplied), which was then centrifuged at 
10000 rpm for 15 seconds. The flow through solution was discarded. After that, 700μl RW1 
buffer (supplied) was added into the column followed by a centrifugation at 10000 rpm for 15 
seconds, the flow through was discarded. In the next step, 500μl of RPE buffer (supplied) was 
added into the column and centrifuged at 10000 rpm for 15 seconds, the flow through was 
discarded. This step was repeated one more time in which the centrifugation time was 2 minutes. 
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The column was then placed onto a new 1.5ml collection tube (supplied) and added with 30μl of 
RNase-free water (supplied) and centrifuged for 1 minute at 10000 rpm to elute the total RNA.  
 The master mix solution was prepared by adding the reagents supplied with appropriate 
concentrations listed in the table 1 below. CDNA was synthesized using High Capacity cDNA 
Reverse Transcription Kit (Applied Bio systems, Fostercity, CA). The concentration of isolated 
total RNA was up to 2μg per 20μl reaction.  
 
Table 1: List of PCR Master Mix Components and Concentrations 
Components Volume/Reaction (μl) 
10X RT buffer 2.0 
25X dNTP Mix (100mM) 0.8 
10X RT Random Primers 2.0 
MuiltiScribeTM Reverse Transcriptase 1.0 
RNase Inhibitor 1.0 
Nuclease-free H2O 3.2 
Total per Reaction 10.0 
   
 The cDNA RT reaction was prepared by mixing 10μl of master mix and 10μl of total 
RNA in each of the individual tubes. Then the tubes were briefly centrifuged and placed into the 




Table 2: cDNA Synthesis Thermo Cycler Conditions 
 Step 1 Step 2 Step 3 Step 4 
Temperature (ºC) 25 37 85 4 
Time (minute) 10 120 5 ∞ 
 
 The purpose of the real-time RT-PCR technique is to amplify DNA using cDNA 
sequences as templates and to quantify the gene expression level based on the measurement of 
fluorescent signals. The DNA-binding dye used in this technique is called SYBR Green I (Bio-
rad Laboratories, Philadelphia, PA), which binds nonspecifically to double-stranded DNA. This 
probe exhibits little green fluorescence in its free form, but when bound to double-stranded 
DNA, its fluorescence increases significantly and is detected by the machine linked with 
computer analysis. Therefore, the intensity of fluorescent signal released during real-time RT-
PCR reaction is proportional to the amount of DNA amplified, which in turn is equivalent to the 
level of mRNA presented. 
 In order to perform the experiment, master mix was prepared by mixing 10μl of SYBR 
Green I, 8μl distilled water, 1μl of forward primer and 1μl of reverse primer for each of the 
reactions. The primer was diluted before used so that its final concentration was 5μM/μl. Then 
the mix was placed into a 96-well PCR plate and the plate was sealed and placed into the 
thermos cycler, which was programed following the conditions listed in table 3 below. The house 
keeping control used in this assay was GAPDH. The primers used are listed in table 4 below. All 
of the primers were customized by Thermo Fisher. Gene expression was normalized to GAPDH 




Table 3: Real-time RT-PCR Thermo Cycler Conditions 
 Step 1 Step 2 Step 3 Step 4 
Temperature (ºC) 95 95 60 60 
Time/cycle 10 min 5 min 60 sec 40 cycles 
 
 
Table 4: List of Primers used in the Study 
Genes to be amplified Primer sequences 
ATM F: 5'-TGGATCCAGCTATTTGGTTTGA-3' 
 R: 5'-CCAAGTATGTAACCAACAATAGAAGAAGTAG-3' 
MRE11A F: 5'-CTTGTACGACTGCGAGTGGA-3' 
 R: 5'-TTCACCCATCCCTCTTTCTG-3' 
RAD50 F: 5'-CTTGGATATGCGAGGACGAT-3' 
 R: 5'-CCAGAAGCTGGAAGTTACGC-3' 
NBN F: 5'-TTGGTTGCATGCTCTTCTTG-3' 
 R: 5'-GGCTGCTTCTTGGACTCAAC-3' 
CHEK2 F: 5'-CCCAAGGCTCCTCCTCACA-3' 
 R: 5'-AGTGAGAGGACTGGCTGGAGTT-3' 
TP53 F: 5'-TCAACAAGATGTTTTGCCAACTG-3' 
 R: 5'-ATGTGCTGTGACTGCTTGTAGATG-3' 
GAPDH F: 5'-TGCACCACCAACTGCCTTAGC-3' 






 Western Blot, also called immunoblotting, is a widely used technique for detection and 
characterization of proteins. The technique principle is based on immunochromatography where 
proteins are separated according to their molecular weights by gel electrophoresis. The separated 
proteins are then transferred and immobilized onto a nitrocellulose membrane where they will be 
bound with primary, then secondary antibodies and detected by chemiluminescence.  This study 
used the Amersham ECL Prime Western Blotting Detection Reagent (GE Healthcare Bio-Sciences, 
Pittsburgh, PA).The western blot protocol consists of five main steps, including protein 
purification, gel electrophoresis, membrane transferring, antibody incubation, and protein 
detection.  
 The protein purification step begins by cell harvesting. Cultured cells were harvested and 
washed with cell staining buffer by centrifugation at 1200 rpm for 5 minutes, followed by 
removal of the. The cell pellet was suspended with homogenization buffer containing no SDS 
RIPA buffer (Thermo Fisher) and 1X protease inhibitor. Then the tube containing the mixture 
was vigorously vortexed for 30 seconds, placed on ice for 5 minutes, shaken for 10 minutes at 
4ºC, and finally was centrifuged at 13000 rpm at 4ºC for 15 minutes. The supernatant, which was 
protein mixture, was collected and transferred into a new tube.  
 The purified proteins were separated by gel electrophoresis. The resolving gel was 
prepared by adding the appropriate amount of reagents listed in table 5 and stacking gel in table 
6 below. The prepared gel was placed into the chamber which contained 1X running buffer (Bio-
Rad Laboratories). The chamber was then connected to the electronic machine, the gel was run 
under the two steps protocol. In step 1, the gel was run under 75V for 80 minutes and in step 2, it 
was 125V for 45 minutes. 
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Table 5: Western Blotting Resolving Gel Preparation Components 
 8% 10% 12% 
Water (mL) 4.6 3.8 3.2 
30% acrylamide (mL) 2.6 3.4 4.0 
1.5M Tris – HCL, pH 8.8 (mL) 2.6 2.6 2.6 
10% SDS (μL) 100 100 100 
10% APS (μL) 100 100 100 
TEMED (μL) 10 10 10 
 
Table 6: Western Blotting Stacking Gel Preparation Components 
 5% 
Water (mL) 5.86 
30% acrylamide (mL) 1.34 
1.5M Tris – HCL, pH 8.8 (mL) 2.6 
10% SDS (μL) 100 
10% APS (μL) 100 
TEMED (μL) 10 
   
 After the separation, the proteins were then transferred onto nitrocellulose membrane 
when the gel and membrane were placed together in the transfer chamber containing transfer 
buffer, made by mixing 10X transfer buffer, methanol and distilled water in the ratio of 1:2:7, 
respectively. The chamber was connected to the electronic machine, which was set at 30V and 
the transfer process took place in the cold room overnight.  
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 The next morning, the membrane was blocked with 5% skim milk in tris-buffered saline 
containing tween (TBST) at room temperature for an hour, then washed three times with TBST. 
After that, the membrane was incubated with primary antibody in BSA solution, in which the 
antibody was diluted 1:1000, overnight in the cold room. In the next step, the membrane was 
washed three times with TBST, then incubated with secondary antibody for 1 hour at room 
temperature. After the incubation, the membrane was again washed three times with TBST, then 
it was dropped with chemiluminescence solution for 5 minutes and detected by Chemi DocTM 
MP Imaging System (Bio-Rad System). All of the antibodies were purchased from Cell 
Signaling. The house keeping protein used in this study was β-Actin.  
Statistical Analysis 
 
 The data was analyzed using Prism 7 software and are presented as mean ± SEM or 
median with interquartile range. Differences between two groups were analyzed by independent 
Student's t test or Mann Whitney test, paired T test, or Wilcoxon matched-pairs signed rank test. 
Multiple groups were analyzed by one-way ANOVA test. P-values <0.05, <0.01, or <0.001 were 














Figure 1: Experimental design 
  
 The general workflow of the study is described in Figure 1. First of all, human whole 
blood was collected from chronically HIV-infected patients and healthy subjects. PBMCs were 
isolated by density-gradient centrifugation. In the next step, the isolated PBMCs were used as the 
source for further purification of total CD4T cells using the CD4T cell isolation kit, which 
includes antibody cocktail and microbeads cocktail and LS column for magnetic separation. 
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Isolated CD4T cells were cultured with RMPI 1640 complete media for 4 days in the incubator 
hood. Cells were then harvested and taken for further assays. The first assay was the phenotype 
analysis of CD4T cell populations by FCM. The second one was the assessment of cellular 
apoptosis using FCM. The next assay performed was DNA damage determination by 
immunofluorescence and confocal microscope. After that, telomere length was determined by 
FCM analysis. Gene expression of proteins involved in the ATM-p53 DDR pathway and 
shelterin complex were evaluated by RNA extraction, cDNA synthesis, and real-time RT-PCR. 
Last but not least, the expression levels of those proteins were estimated by western blotting.  
 The data collected after these assays will be analyzed and compared between Healthy and 
HIV-infected subjects using unpaired t-test. If the p value is smaller than 0.05 or even < 0.001, 
then the results between the two groups are regarded having significant or very significant 












CD4T Cells Homeostasis and Apoptotic Susceptibility in Latently HIV-infected Individuals 
on ATR Treatment 
 As mentioned by previous studies, T cell dysregulation is a specific characteristic caused 
by chronic viral infections, including HIV infection. However, the detailed mechanism by which 
viral infections persistently trigger the response of immune system, eventually resulting in the 
loss of T cell homeostasis, still remains unclear. In order to determine the characteristics of T 
cells in latently HIV-infected patients, T cell phenotypic analysis by FCM was performed with 
the collected data in Figure 2, which is a representative dot plot and summary data from FCM 
analysis. In this assay, the number of lymphocytes, including total CD4+, naïve CD4+CD45RA+ 
and memory CD4+CD45RA- helper T cells present in PBMCs of HIV-infected patients (n=24)  
and age-matched healthy subjects (n=27) was determined. As shown in the figure, the 
percentages of these cells in PBMCs of HIV-infected patients were significantly less than 
healthy subjects, in which the differences of total CD4 (p=0.0001) and memory CD4 (p=0.0001) 
were considered very significant with small p values. In addition, naïve CD4were also 
considered to be significant with p=0.043. The percentages of memory CD4T cells, including 
central memory (CD4+CD45RA-CCR7+CD28+), effector memory (CD4+CD45RA-CCR7-
CD28+/-) and terminally differentiated memory (CD4+CD45RA-CCR7-CD28+) were further 
investigated. The results indicated that all three subpopulations of memory CD4T cells were 
significantly decreased in HIV-infected patients compared to healthy subjects. Among those, 
central memory CD4cells had the most significant difference (data not shown). The contractions 
of CD4T cells, especially central memory CD4T cells in HIV-infected individuals compared to 
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healthy subjects, are consistent with previous reports which indicated that T cells are exhausted 
and senescent in latent HIV infected individuals.    
 
Figure 2: Percentage of lymphocytes in PBMCs analyzed by FCM. PBMCs were isolated 
from 24 HIV-infected patients and 27 healthy subjects analyzed for T cell homeostasis by FCM. 
Representative dot plots and summary data for the homeostasis of T cell populations are shown. 
Total CD4T cells were defined as CD4+, naïve CD4as CD4+CD45RA+ and memory CD4as 
CD4+CD45RA-. Each dot represents an individual. The means, ± SD and p values are also 
shown.  
 
 The T cells repertoire in PBMCs is well balanced between the number of newly 
synthesized T cells and the number of dying T cells via programmed cell death or their 
engagement with pathogens, within the existing T cell population. Chronic viral infection usually 
triggers the central memory CD4T cells to produce more and more effector CD4cells to suppress 
the viral concentration. Long term, the continuous generation of effector T cells by central 
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memory T cells leading to proliferative turnover, causes loss of homeostasis, telomere erosion, 
and ultimately, cellular apoptosis. In order to determine the apoptosis level in CD4T cells, these 
cells were stained with apoptotic markers Annexin V and 7-AAD and analyzed by FCM 
analysis, the collected data is shown in Figure 3.  
 
Figure 3: The percentage of Av+/7-AAD positive CD4 populations. PBMCs from 8 
individuals of each HIV-infected and healthy subject groups were isolated and analyzed by FCM 
analysis. Representative dot plots and summary data for percentage of Av+/7-AAD expression in 
CD4populations. Total CD4T cells were defined as CD4+, naïve CD4as CD4+CD45RA+ and 
memory CD4as CD4+CD45RA-. Each dot represents an individual. The means, ± SD and p 
values are also shown.  
 
 It can be observed that, the expressions of early apoptotic markers were significantly 
higher in all subpopulations of CD4T cells in HIV-infected patients compared to healthy 
subjects. The p values were p=0.0050, p=0.0013 and p=0.0006 for total, naïve and memory 
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CD4T cells, respectively. In order to evaluate the correlation between T cell exhaustion and 
cellular apoptosis, the data collected by FCM was then further analyzed by Pearson Correlation 
(PC) analysis. Figure 4 shows a negative correlation between the percentage of total and memory 
CD4T cells in PBMCs and the level of cellular apoptosis in HIV-infected patients, in which the 
lower the concentration of CD4T cells, the higher the apoptotic marker expressions are and vice 
versa, with r=-0.4416, p=0. 0868 and n=8 for each HIV-infected and healthy subjects.  
 
 
Figure 4: The Pearson Correlation analysis between percentage of CD4T cells and 
apoptosis. PBMCs from 8 individuals of each HIV-infected and healthy subject groups were 
isolated and analyzed by FCM analysis.  
 
 In addition, FCM data analyzed by PC analysis in Figure 4 also showed that there was a 
positive correlation between the percentage and the actual counts of CD4cells. The above data 
suggests a close correlation between T cell exhaustion and cellular apoptosis, in which 





Figure 5: The Pearson Correlation analysis between percentage of CD4T cells and the 
actual CD4T cell counts in HIV infected-patients. The r and p values are shown in the figure. 
CD4 T cell Exhaustion and Senescence in Latent HIV Infection 
 To further characterize the T cell exhaustion and senescence in latent HIV infection, we 
further investigated the expressions of relevant markers in both HIV-infected patients and age-
match healthy subjects by FCM analysis. The first marker used was programmed cell death 1 
protein (PD1), which was considered as marker of T cell exhaustion. As showed in Figure 6, the 
expression of this protein was significantly higher in HIV-infected patients when compared to 
healthy subjects both in lymphocyte population with p=0.0055, and CD4T cell alone with 
p=0.0231. On the other hand, the expressions of PD1 protein in CD4T cells who were at resting 





Figure 6: Percentage of PD1 protein in lymphocytes and CD4 T cells analyzed by FCM 
analysis. Lymphocytes and total CD4T cells were isolated and analyzed by FCM for PD1 
determination. Each dot in the figure represents an individual. The means, ± SD and p values are 
also shown. 
 The next relevant marker used for comparison between HIV-infected patients and healthy 
subjects was CD28 protein, a co-receptor necessary for T cell activation and survival. Therefore, 
the loss of this protein is equivalent to T cell senescence. However, as shown in Figure 7, there 
was no significant difference in the expression of this marker in CD4T cells in HIV-infected 
patients compared to healthy subjects. Another marker evaluated was CD57 protein, which is 
considered as the specific marker for a subset of T lymphocytes called natural killer cells. 
Besides its well-known role, CD57 protein has been considered to represent a marker for T cell 
exhaustion. It can be observed in Figure 7, there was a significant different in the expression of 
CD57 protein in HIV-infected patients and healthy subjects, in which there was a much higher 
concentration of this protein found on the membrane of HIV-infected patients’ T cells, p=0.0059. 
This data suggested that chronic HIV-infection causes cellular exhaustion and senescence in T 




Figure 7: The percentage of CD28 and CD57 protein expressions in CD4T cells analyzed by 
FCM. The number of individuals in each HIV-infected and healthy subject groups are shown. 
Each dot in the figure represents an individual. The means, ± SD and p values are also shown. 
 
Telomere Attrition and Telomeric DNA Damage in CD4 T Cells during Latent HIV 
Infection 
 The importance of telomere function was mentioned in the introduction since telomeres, 
together with its associated proteins, act as a shield to protect genome stability from DNA 
damage and to prevent cellular senescence. Without their protection, the genomic integrity would 
be corrupted and result in serious diseases. To further investigate the telomere function and the 
wealth of telomeric DNA in latent HIV infection, telomere lengths of HIV infected individuals 
and healthy subjects were measured by FCM analysis using the median fluorescence intensity 
(MFI) generated from the fluorescent signal of telomeric DNA complementary probes. The 
higher the MFI, the longer the telomere length. Collected data is represented in Figure 8, which 
showed that the telomere length of CD4T cell populations in HIV-infected patients was shorter 
than for healthy subjects. Among those, telomere lengths of total and memory CD4T cells from 
HIV-infected patients were significantly lower with p=0.0423 and p=0.0260, respectively. 
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However, there was no significant difference in the telomere length of naïve CD4population 
between the two groups (p=0.1467). 
 
 
Figure 8: Telomere length determination by Flow-FISH analysis. CD4T cells from 24 
samples from each of HIV-infected patient and healthy subject groups were isolated and had 
their telomere length determined by Flow-FISH analysis. Representative dot plots, summary 
data, and flow cytometry histogram are shown. Each dot in the figure represents an individual. 
The means, ± SD and p values are also shown. 
 
 More importantly, when the cells were measured for both telomere length MFI and 
cellular apoptosis markers, Annexin V and 7-AAD,  PC data analysis indicates, as shown in 
Figure 9, a negative correlation between cellular apoptosis and telomere length in HIV-infected 
patients, with r=-0.3318 and p=0.0212. It can be observed that the shorter the telomere length, 




Figure 9: Pearson correlation analysis of the telomere length (MFI) and the percentage of 
early apoptotic cells. The r and p values are shown in the figure. 
 
CD4 T cell Exhaustion and Senescence in Latent HIV Infection 
 
 This data indicated that telomere erosion is closely associated with apoptosis in latent 
HIV infection. In addition, it also raised a question regarding the unknown mechanism or 
pathway causing telomere shortening and cellular apoptosis in latent HIV infection while the 
patients were under ART treatment with undetectable viral load in their blood. One of the 
possible explanations is the increase in concentration of reactive oxygen species (ROS), a 
substance which plays important roles in many cellular processes at appropriate concentration. 
The excess amount of ROS could cause extreme harm to cellular health, such as oxidative stress. 
In order to test this hypothesis, the level of ROS present in HIV-infected patients and healthy 
subjects was measured using Cellular ROS Detection Kit based on the absorption of DCFDA 
which can be bound with cytochrome c enzyme, a protein involved in cellular respiration 
together with the release of ROS substance via the process. As shown is Figure 10, the level of 
DCFDA signal generated by HIV-infected patients was higher when compared to healthy 
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subjects in cells cultured for 1 day (p=0.0939) and significantly higher in cells cultured for 4 
days (p=0.0035), indicating there was a higher ROS concentrations in HIV-infected individuals.  
 
 
Figure 10: Median Fluorescence Intensity of DCFDA in HIV-infected patients and healthy 
subjects. CD4T cells of 10 individuals from each group were isolated and determined for the 
MFI of DCFDA by FCM analysis. Each dot in the figure represents an individual. The means, ± 
SD and p values are also shown. 
 
 However, because the principle in measuring ROS of this kit is based on the level of 
cytochrome c, which is usually through the mitochondrial membrane into cytosol during 
apoptosis, it is dependent on the apoptosis pathway and it could not tell us whether ROS, 
independent of the apoptosis pathway, actually have any impact on the telomere erosion and 
trigger the apoptosis or not. Because of that, another ROS measuring method was used, called 
CellROX Green kit, which actually forms direct binding with ROS substances. In this 
experiment, cells from HIV-infected patients and healthy subjects were stained with both 
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CellROX green fluorescence and apoptotic marker, Annexin V, and the results were similar to 
the previous measurement. Furthermore, stained cells were then gated into two different 
populations, Av+ROSlow and Av+ROShigh. As shown in Figure 11, in both HIV-infected and 
healthy subjects, cells which expressed high apoptotic marker had low levels of ROS, and vice 
versa. It was also worth noting that the HIV-infected patients expressing higher concentrations of 
cells had Av+ROSlow, on the other hand, cells that had Av+ROShigh expressed much more in 
healthy subjects.  
 
 
Figure 11: Mean Fluorescence Intensity of CellROX Green and Annexin V in CD4T cells of 
HIV-infected and healthy subjects. Representative dot plots and summary data of the 
MFI as well as % of the two gated cell populations (AV- ROXhigh and Av+ ROXlow) from 
three subjects in each group are shown. Each dot in the figure represents an individual. 
 
 After the determination of telomere length and cellular apoptosis, to further confirm our 
hypothesis, level of telomeric DNA damages in HIV-infected patients and healthy subjects were 
measured by immunofluorescence staining and confocal microscope. As mentioned in the 
Materials and Methods section, the telomeric DNA damage was determined based on the number 
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of co-localizations of telomeric protein TRF1 and DNA damage marker 53BP1, also called 
telomere induced foci (TIF).  
 
 
Figure 12: Confocal microscope analysis of the co-localization of 53BP1 and TRF1 proteins 
in CD4T cells isolated from HIV-infected and healthy subjects. CD4T cells of 8 subjects 
from each group were isolated, determined for the co-localization by immunofluorescence assay, 
and visualized by confocal microscope. The number of telomere induced foci (TIFs) in the 
nucleus of those cells was also measured. Each dot in the figure represents an individual. The 
means, ± SD and p values are also shown. 
 As shown in Figure 12, the number of TIF per nucleus of cells in HIV-infected patients 
was significantly higher compared to healthy subjects (p=0.0029). In addition, the percentage of 
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cells which had more than three TIF per cell was also higher in HIV-infected patients 
(p=0.0340).  
 Moreover, the expression levels of γH2AX, a protein considered as a marker of DNA 
damage, was evaluated in both HIV-infected individuals and healthy subjects by FCM analysis.  
 
 
Figure 13: Percentage and Median Fluorescence Intensity of γH2AX determined by FCM 
analysis. Total, naïve, and memory CD4T cells of 16 subjects from HIV-infected and healthy 
subject groups were isolated and determined for γH2AX percentage and MFI by FCM. Each dot 
in the figure represents an individual. The means, ± SD and p values are also shown. 
 
 As shown in Figure 13, the MFI level of γH2AX protein expression of CD4populations 
in HIV-infected patients was significantly higher compared in healthy subjects, in which the p 
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value for total CD4was 0.0192, naïve CD4was 0.0087 and memory CD4was 0.0148. Likewise, 
γH2AX expression was also higher in HIV-infected subjects with p=0.0383. These results 
suggested that telomere dysfunction caused telomeric DNA damage, which in turn triggered 
cellular apoptosis in latent HIV infection. 
ATM Expression and Activity are Inhibited in CD4 T Cells during Latent HIV Infection 
 Accumulation of DNA damage and higher incidence of cellular apoptosis indicates that 
the DDR machineries are not functioning properly as hypothesized. In this project, ATM-related 
DDR pathway was the main interest. The pathway functions by sending cascade signals from 
sensors to transducer, further down to mediator and finally is effector proteins. Therefore, any 
dysfunction of involved proteins could have a great negative impact on the whole system. As 
mentioned in the Introduction, the sensor of ATM-related DDR is MRN complex, which 
translocate to the damage site and activates the auto-phosphorylation of transducer protein, ATM 
kinase. Activated ATM kinase in turn phosphorylates mediators such as CHK2 and p53 proteins, 
who can further transduce the signal to effector proteins to cause cell cycle arrest and checkpoint 
activation. In order to investigate the performance of ATM-related DDR pathway, the involved 
proteins were evaluated by both the transcription level by real-time RT-PCR and translation level 
by Western Blotting. As shown in Figure 14, the gene and protein expression levels of MRN 
complex, including MRE11 (p=0.1830), RAD50 (0.7124) and NBS1 (0.7920) proteins, were 




Figure 14: Gene and protein expressions of MRN complex determined by Real-time RT-
PCR and Western Blotting, respectively. CD4T cells of 8 subjects from HIV-infected and 
healthy subject groups were isolated and had their gene and protein expression measured.  
 
 Likewise, shown in Figure 15, there was no difference in the gene expression of ATM 
between the two groups, p=0.2103. However, protein expression of both ATM and 
phosphorylated ATM (p-ATM) proteins, was significantly suppressed in the HIV-infected 
patients compared to healthy subjects, with p=0.0107 and p=0.0031, respectively.  






Figure 15: ATM and phosphorylated ATM gene and protein expressions determined by 
Real-time RT-PCR and Western Blotting. CD4T cells of 9 subjects (for gene expression) and 
16 subjects for protein expression from HIV-infected and healthy subject groups were isolated 
and had their transcription and translation expression levels measured. Each dot in the figure 
represents an individual. The means, ± SD and p values are also shown. 
 
  To further strengthen the data, ATM protein expressions in CD4populations from HIV-
infected individuals and healthy subjected were measured by FCM analysis. As shown is Figure 
16, ATM protein expression in all populations of CD4T cells from HIV-infected patients was 
significantly lower than healthy subjects, in which the p values for total CD4was 0.0060, naïve 
CD4was 0.0254 and memory CD4was 0.0091. This data confirmed that HIV-infected subjects 




Figure 16: Median Fluorescence Intensity of phosphorylated ATM kinase measured by 
FCM analysis. Total, naïve, and memory CD4T cells of 8 subjects from HIV-infected and 
healthy subject groups were isolated and determined for MFI of phosphorylated ATM protein by 
FCM.  Each dot in the figure represents an individual. The means, ± SD and p values are also 
shown. 
 
 To further investigate the function of ATM-related DDR pathway, the expressions of 
down-stream proteins involved in the pathway were determined. As shown in Figure 17, while 
there was no difference in the gene expressions of CHK2 and p53 proteins, the FCM analysis 
showed that the expression of phosphorylated CHK2 protein was significantly lower in HIV-





Figure 17: Gene expression and Median Fluorescence Intensity of ATM downstream 
proteins determined by Real-time RT-PCR. CD4T cells of 9 subjects (for gene expression) 
and 8 subjects (for MFI detection) from HIV-infected and healthy subject groups were isolated 
and determined for transcription level and MFI of CHK2 and p53 proteins. Each dot in the figure 
represents an individual. The means, ± SD and p values are also shown. 
 
 The translation expressions of those proteins were determined by Western Blotting. As 
shown in Figure 18, there was no difference in p53 protein expression between HIV-infected and 
healthy subjects, p=0.6742. However, the expression of CHK2 was significantly lower in HIV-
infected patients, p=0.0296. Another thing worth noting is the expression of PARP, a protein 
involving the DNA repair machinery, and cleaved PARP, which is a cleaved form of PARP after 
engaging in DNA damage reparation. It can be observed that, the level of PARP expression was 
significantly lower and cleaved PARP expression was high in HIV-infected subjects, p=0.0053. 
This data suggested that the heart proteins of ATM-related DDR pathway, which were ATM and 
CHK2, were dysfunctional, causing great affects to the whole crucial pathway, leading to the 





Figure 18: Protein expressions of ATM downstream proteins determined by Western 
Blotting. CD4T cells of 16 subjects (CHK expression detection) and 12 subjects (cleaved PARP 
expression detection) from HIV-infected and healthy subject groups were isolated and 
determined for translation level of CHK2, p53 and cleaved PARP proteins by Western Blotting.  
Each dot in the figure represents an individual. The means, ± SD and p values are also shown. 
TRF2 Expression and Activity are Inhibited in CD4 T cells during Latent HIV Infection 
 Until now, all of the collected data had supported the first part of our hypothesis in which 
the dysfunction of ATM-related DDR pathway resulted in the increase in the accumulation of 
unrepaired telomeric DNA damages. However, the answer to the question whether it was the 
only factor that contributed to the DNA damage increase or if other factors were involved, such 
as the dysfunction of shelterin whose function was to protect the telomere. Our hypothesis was 
that if any components of this complex did not function properly, it could affect the function of 
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the whole complex and thus the complex would fail to protect the telomere ends. In order to 
confirm the hypothesis, the gene and protein expressions of each of the components of the 
shelterin complex were measured. As shown in Figure 19, there was no significant difference in 
the gene expression of the shelterin protein between HIV-infected and healthy subjects.  
 
 
Figure 19: Transcription expressions of proteins in shelterin complex determined by Real-
time RT-PCR. CD4T cells of 8 subjects  from HIV-infected and healthy subject groups were 
isolated and determined for transcription levels of shelterin proteins, including TRF1, TRF2, 
TPP1, TIN2, RAP1 and POT1. The means and ± SD are also shown. 
 
 Furthermore, as shown in Figure 20, there was also no significant difference in the 
protein expressions of those proteins between the two groups, except for TRF2 protein 
(p=0.0163), whose expression was much lower in HIV-infected patients. This data suggested that 
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the low expression of TRF2 protein had caused the entire shelterin complex to be compromised, 
therefore it could not protect the telomere, leading to the increase in the telomeric DNA damage.  
 
 
Figure 20: Translation expressions of proteins in shelterin complex determined by Western 
blotting. CD4T cells of 8 subjects  from HIV-infected and healthy subject groups were isolated 
and determined for translation levels of shelterin proteins, including TRF1, TRF2, TPP1, TIN2, 









 T cells play a crucial role in protecting us from pathogens, especially viral infections. The 
dysfunction of T cells, telomere attrition, as well as failure of the DDR mechanism result in the 
accumulation of unrepaired DNA damage, cellular senescence, and apoptosis. In this study, we 
investigated the integrity of the ATM-related DDR pathway and the shelterin complex in latent 
HIV-infected subjects and compared this to age- matched healthy subjects. We found that the 
levels of CD4cells, including its subpopulations such as total, naïve, and memory CD4T cells, 
were significantly lower in HIV infected subjects than in healthy subjects. Furthermore, these 
cells were not only suppressed, but also exhibited DNA damaged as evidenced by 
overexpression of DNA damage markers such γH2AX, as well as a large number of telomere 
induced foci in the nucleus when examined under a confocal microscope.  
Furthermore, high expression of apoptotic markers, such as PD1 and ROS substances 
were noted in these dysfunctional CD4T cells. Similarly, the buildup of cellular senescence 
markers such as CD28 and CD57 were noted in these cells. These markers are an evidence of T 
cell abnormality and shortened telomere length. This means that the shorter the telomere length, 
the higher the chances of DNA damage, cellular senescence, and apoptosis.   
 In addition, we explored a possible mechanism of the cellular dysfunction in these 
suppressed cells. Our results revealed a flaw in the ATM-related DDR pathway in these HIV-
infected individuals. Surprisingly, even though the DNA damage sensor MRN complex 
remained intact, the expression of ATM kinase (the core of the pathway) was inhibited as 
evidenced by Western Blotting. Similarly, the expression of CHK2 protein, an important ATM 
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downstream protein, was noticeably suppressed in these individuals. Due to the inhibition of 
these key players, the ATM-related DDR pathway failed to repair the persistent DNA damage 
caused by chronic HIV infection. This caused the accumulation of DNA damaged CD4cells in 
the infected individuals.  
Following the deficiency of ATM and its downstream CHK2, we tried to ascertain the 
shelterin integrity. Surprisingly, while there was no abnormality in the gene expressions of 
TRF1, TIN2, TPP1, POT and RAP1, the expression of TRF2 protein was significantly inhibited 
in HIV-infected patients compared to healthy subjects. This result suggests that TRF2 could be 
the key protein protecting the telomeric DNA and as such, its inhibition may be the reason for 
the poor function of the shelterin complex. These results confirmed our hypothesis as we 
expected that a bridge in the ATM-related DDR pathway and shelterin integrity could contribute 
to the DNA damage, cellular senescence, and apoptosis in latent HIV-infected subjects.  
 The findings in this study have provided fundamental insights for future research in T cell 
function in latent HIV-infected patients. Since we have established that the expression of ATM 
and TRF2 proteins are inhibited in HIV infected subjects, this could be further explored.  Studies 
involving knockout of ATM kinase or TRF2 in healthy subjects by siRNA transfection or the use 
of ATM and TRF2 inhibitors could be done. Similarly, ATM kinase and TRF2 overexpression 
experiments could be explored in chronic HIV-infected subjects to see if these dysfunctional 
cells could be rescued from DNA damage and apoptosis. In addition, in vitro studies or the mice 
models could be used to study the function of these proteins and pathway. Finally, other DDR 
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